Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Hazard Ratio | 95% CI | p-value | Hazard Ratio | 95% CI | p-value | |
Location of primary tumor (Rectum) | 0.786 | 0.452-1.369 | 0.395 | |||
Histological type (Poorly, Mucinous) | 1.251 | 0.533-2.940 | 0.607 | 1.735 | 0.667-4.513 | 0.259 |
Detection of unresectable tumor (Metachronous) | 0.653 | 0.327-1.304 | 0.227 | |||
Distant metastasis except peritoneal dissemination (Yes) | 0.684 | 0.271-1.726 | 0.421 | |||
Peritoneal dissemination (Yes) | 1.411 | 0.771-2.582 | 0.264 | 1.888 | 0.641-5.561 | 0.249 |
The number of organs affected by metastasis (≥2) | 1.054 | 0.602-1.847 | 0.853 | 0.488 | 0.184-1.291 | 0.148 |
Pretreatment CEA (>5 ng/ml) | 1.385 | 0.590-3.253 | 0.455 | |||
Pretreatment CA19-9 (>37 U/ml) | 1.619 | 0.900-2.913 | 0.108 | |||
Molecular targeted therapy (Yes) | 0.751 | 0.432-1.306 | 0.310 | |||
Cholinesterase (<235 IU/l) | 0.915 | 0.289-2.890 | 0.879 | |||
Cholesterol (<200 mg/dl) | 1.180 | 0.408-3.406 | 0.760 | |||
NLR (>2.8) | 2.639 | 1.383-5.035 | 0.003 | 2.457 | 1.165-5.182 | 0.018 |
GPS (2) | 2.558 | 0.900-7.269 | 0.078 | 1.237 | 0.466-3.287 | 0.670 |
AGR (>1.25) | 1.946 | 1.033-3.668 | 0.039 | 2.247 | 1.069-4.722 | 0.033 |